{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:34:36Z","timestamp":1785270876292,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Epidural administration of morphine has been shown to be an effective analgesic strategy in horses; however, the possible occurrence of side effects limits its usage. In order to decrease their frequency, it is important to target the minimal effective plasma concentration and avoid overdosing. As to date species-specific pharmacokinetics data are not available for epidural morphine, the dosing regimen is usually established on the basis of clinical reports and personal experience. In certain physiological conditions, like gestation, the outcome of an empirical dosing scheme can be unpredictable. The aim of this case report is to describe the pharmacological profile of morphine and its metabolites after prolonged epidural administration in a pregnant mare and her foal.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 20\u2009years old pregnant mare was presented to our hospital because of severe lameness, 2\u00a0months before delivery. Following an ineffective systemic pain treatment, an epidural catheter was inserted and morphine administered (initial dose 0.1\u2009mg\/kg every 8\u2009h). Due to its efficacy in controlling pain, it was continued until end of gestation. Plasmatic concentration of morphine and its metabolites were assessed in the mare 6\u2009weeks after starting the treatment, and in both the mare and foal during the first days after delivery. Plasmatic values similar to those previously reported in the literature following morphine short term administration through various routes and not accompanied by side effects were found in the mare, except during an excitatory period. Moreover, no evidence of dangerous drug accumulation or significant milk passage was noticed in the foal. Mild reduction of feces production with no signs of colic and two self-limiting episodes of excitement occurred during treatment in the mare. No side effects occurred during gestation and first phases of life in the foal.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Prolonged epidural administration of morphine in a pregnant mare allowed good pain control in absence of clinically relevant side effects, in both the mare and her foal. Sudden increase in morphine plasmatic concentration can occur and side effects appear; careful treatment to the lowest effective dose and continuous monitoring of the clinical condition of the treated horse should be performed.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12917-020-2242-9","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T18:02:27Z","timestamp":1579543347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Morphine plasmatic concentration in a pregnant mare and its foal after long term epidural administration"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-7500","authenticated-orcid":false,"given":"Alessandro","family":"Mirra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Birras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Diez Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Spadavecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"2242_CR1","first-page":"211","volume":"31","author":"A Valverde","year":"1990","unstructured":"Valverde A, Little CB, Dyson DH, Motter CH. Use of epidural morphine to relieve pain in a horse. Can Vet J. 1990;31:211\u20132.","journal-title":"Can Vet J"},{"key":"2242_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1053\/jvet.2002.32436","volume":"31","author":"LR Goodrich","year":"2002","unstructured":"Goodrich LR, Nixon AJ, Fubini SL, Ducharme NG, Fortier LA, Warnick LD, Ludders JW. Epidural morphine and detomidine decreases postoperative hindlimb lameness in horses after bilateral stifle arthroscopy. Vet Surg. 2002;31:232\u20139.","journal-title":"Vet Surg"},{"key":"2242_CR3","doi-asserted-by":"publisher","first-page":"e000275","DOI":"10.1136\/vetreccr-2015-000275","volume":"4","author":"D Rodrigo-Mocholi","year":"2016","unstructured":"Rodrigo-Mocholi D, Steblaj B, Vlaminck L, Gasthuys F, Schauvliege S. Continuous caudal epidural analgesia for perioperative pain control after bilateral mastectomy in a mare. Vet Rec Case Rep. 2016;4:e000275. https:\/\/doi.org\/10.1136\/vetreccr-2015-000275.","journal-title":"Vet Rec Case Rep"},{"key":"2242_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2460\/ajvr.73.6.799","volume":"73","author":"JP Figueiredo","year":"2012","unstructured":"Figueiredo JP, Muir WW, Sams R. Cardiorespiratory, gastrointestinal, and analgesic effects of morphine sulfate in conscious healthy horses. Am J Vet Res. 2012;73:799\u2013808. https:\/\/doi.org\/10.2460\/ajvr.73.6.799.","journal-title":"Am J Vet Res"},{"key":"2242_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/vaa.12133","volume":"41","author":"M Martin-Flores","year":"2014","unstructured":"Martin-Flores M, Campoy L, Kinsley MA, Mohammed HO, Gleed RD, Cheetham J. Analgesic and gastrointestinal effects of epidural morphine in horses after laparoscopic cryptorchidectomy under general anesthesia. Vet Anaesth Analg. 2014;41:430\u20137. https:\/\/doi.org\/10.1111\/vaa.12133.","journal-title":"Vet Anaesth Analg"},{"key":"2242_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1532-950X.1997.tb01477.x","volume":"26","author":"AM Sysel","year":"1997","unstructured":"Sysel AM, Pleasant RS, Jacobson JD, Moll HD, Warnick LD, Sponenberg DP, Eyre P. Systemic and local effects associated with long-term epidural catheterization and morphine-detomidine administration in horses. Vet Surg. 1997;26:141\u20139.","journal-title":"Vet Surg"},{"key":"2242_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/jvp.12098","volume":"37","author":"HK Knych","year":"2014","unstructured":"Knych HK, Steffey EP, McKemie DS. Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses. J Vet Pharmacol Ther. 2014;37:374\u201381. https:\/\/doi.org\/10.1111\/jvp.12098.","journal-title":"J Vet Pharmacol Ther"},{"key":"2242_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1365-2125.1992.tb04121.x","volume":"34","author":"R Osborne","year":"1992","unstructured":"Osborne R, Thompson P, Joel S, Trew D, Patel N, Slevin M. The analgesic activity of morphine-6-glucuronide. Br J clin Pharmac. 1992;34:130\u20138.","journal-title":"Br J clin Pharmac"},{"key":"2242_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1620\/tjem.105.45","volume":"105","author":"K Shimomura","year":"1971","unstructured":"Shimomura K, Kamata O, Ueki S, Ida S, Oguri K, Yoshimura H, Tsukamoto H. Analgesic effect of morphine Glucuronides. Tohoku J Exp Med. 1971;105:45\u201352.","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"2242_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","volume":"47","author":"MT Smith","year":"1990","unstructured":"Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide--a potent antagonist of morphine analgesia. Life Sci. 1990;47(6):579\u201385.","journal-title":"Life Sci"},{"key":"2242_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1213\/01.ANE.0000059225.40049.99","volume":"97","author":"K Hemstapat","year":"2003","unstructured":"Hemstapat K, Monteith GR, Smith D, Smith MH. Morphine-3-Glucuronide\u2019s Neuro-excitatory effects are mediated via indirect activation of N-methyl-d-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal Neurones. Anesth Analg. 2003;97:494\u2013505.","journal-title":"Anesth Analg"},{"issue":"1","key":"2242_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/vaa.12212","volume":"42","author":"KB Gleerup","year":"2015","unstructured":"Gleerup KB, Forkman B, Lindegaard C, Andersen PH. An equine pain face. Vet Anaesth Analg. 2015;42(1):103\u201314. https:\/\/doi.org\/10.1111\/vaa.12212.","journal-title":"Vet Anaesth Analg"},{"key":"2242_CR13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1590\/S0103-84782006000500014","volume":"36","author":"CC Natalini","year":"2006","unstructured":"Natalini CC. Plasma and cerebrospinal fluid alfentanil, butorphanol, and morphine concentrations following caudal epidural administration in horses. Ci\u00eancia Rural. 2006;36:1436\u201343. https:\/\/doi.org\/10.1590\/S0103-84782006000500014.","journal-title":"Ci\u00eancia Rural"},{"issue":"10","key":"2242_CR14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.bcp.2011.03.001","volume":"81","author":"N Fr\u00f6lich","year":"2011","unstructured":"Fr\u00f6lich N, Dees C, Paetz C, Ren X, Lohse MJ, Nikolaev VO, Zenk MH. Distinct pharmacological properties of morphine metabolites at G(i)-protein and \u03b2-arrestin signaling pathways activated by the human \u03bc-opioid receptor. Biochem Pharmacol. 2011;81(10):1248\u201354. https:\/\/doi.org\/10.1016\/j.bcp.2011.03.001.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"2242_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2165\/00003088-200140070-00001","volume":"40","author":"J L\u00f6tsch","year":"2001","unstructured":"L\u00f6tsch J, Geisslinger G. Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet. 2001;40(7):485\u201399.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2242_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1191\/026921699678158579","volume":"13","author":"S Mercadante","year":"1999","unstructured":"Mercadante S. The role of morphine glucuronides in cancer pain. Palliat Med. 1999;13(2):95\u2013104.","journal-title":"Palliat Med"},{"issue":"26","key":"2242_CR17","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1016\/0024-3205(87)90431-0","volume":"41","author":"GW Pasternak","year":"1987","unstructured":"Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 1987;41(26):2845\u20139.","journal-title":"Life Sci"},{"issue":"8569","key":"2242_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0140-6736(87)91341-9","volume":"2","author":"CW Hand","year":"1987","unstructured":"Hand CW, Blunnie WP, Claffey LP, McShane AJ, McQuay HJ, Moore RA. Potential analgesic contribution from morphine-6-glucuronide in CSF. Lancet. 1987;2(8569):1207\u20138.","journal-title":"Lancet"},{"issue":"10","key":"2242_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0024-3205(95)00010-4","volume":"56","author":"C Mignat","year":"1995","unstructured":"Mignat C, Wille U, Ziegler A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 1995;56(10):793\u20139.","journal-title":"Life Sci"},{"issue":"1","key":"2242_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0014-2999(91)90199-Z","volume":"193","author":"QL Gong","year":"1991","unstructured":"Gong QL, Hedner T, Hedner J, Bj\u00f6rkman R, Nordberg G. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol. 1991;193(1):47\u201356.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2242_CR21","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0006-2952(01)00761-4","volume":"62","author":"C Ulens","year":"2001","unstructured":"Ulens C, Baker L, Ratka A, Waumans D, Tytgat J. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies. Biochem Pharmacol. 2001;62(9):1273\u201382.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"2242_CR22","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/j.1360-0443.1997.tb02877.x","volume":"92","author":"GK Hulse","year":"1997","unstructured":"Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997;92(11):1571\u20139.","journal-title":"Addiction"},{"issue":"2","key":"2242_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0002-9378(16)33250-1","volume":"127","author":"JD Madden","year":"1977","unstructured":"Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol. 1977;127(2):199\u2013201.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2242_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","volume":"116","author":"C Dryden","year":"2009","unstructured":"Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG. 2009;116(5):665\u201371. https:\/\/doi.org\/10.1111\/j.1471-0528.2008.02073.x.","journal-title":"BJOG"},{"issue":"5","key":"2242_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1465-3362.2010.00176.x","volume":"29","author":"L Burns","year":"2010","unstructured":"Burns L, Conroy E, Mattick RP. Infant mortality among women on a methadone program during pregnancy. Drug Alcohol Rev. 2010;29(5):551\u20136. https:\/\/doi.org\/10.1111\/j.1465-3362.2010.00176.x.","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"2242_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/10550881003684871","volume":"29","author":"ES Bandstra","year":"2010","unstructured":"Bandstra ES, Morrow CE, Mansoor E, Accornero VH. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis. 2010;29(2):245\u201358. https:\/\/doi.org\/10.1080\/10550881003684871.","journal-title":"J Addict Dis"},{"issue":"2","key":"2242_CR27","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","volume":"129","author":"M. L. Hudak","year":"2012","unstructured":"Hudak ML, Tan RC; Committee on drugs; committee on fetus and newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012; 129(2): e540\u2013e560. doi: https:\/\/doi.org\/10.1542\/peds.2011-3212.","journal-title":"PEDIATRICS"},{"issue":"5","key":"2242_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1399-6576.1989.tb02938.x","volume":"33","author":"VL Feilberg","year":"1989","unstructured":"Feilberg VL, Rosenborg D, Broen Christensen C, Mogensen JV. Excretion of morphine in human breast milk. Acta Anaesthesiol Scand. 1989;33(5):426\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"2242_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1399-6576.1993.tb03769.x","volume":"37","author":"MI Zakowski","year":"1993","unstructured":"Zakowski MI, Ramanathan S, Turndorf H. A two-dose epidural morphine regimen in cesarean section patients: pharmacokinetic profile. Acta Anaesthesiol Scand. 1993;37(6):584\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"2242_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1213\/ANE.0000000000001143","volume":"122","author":"J Ansari","year":"2016","unstructured":"Ansari J, Carvalho B, Shafer SL, Flood P. Pharmacokinetics and pharmacodynamics of drugs commonly used in pregnancy and parturition. Anesth Analg. 2016;122(3):786\u2013804. https:\/\/doi.org\/10.1213\/ANE.0000000000001143.","journal-title":"Anesth Analg"},{"issue":"6","key":"2242_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/bja\/aeu186","volume":"113","author":"R Klimas","year":"2014","unstructured":"Klimas R, Mikus G. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Br J Anaesth. 2014;113(6):935\u201344. https:\/\/doi.org\/10.1093\/bja\/aeu186.","journal-title":"Br J Anaesth"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-2242-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-020-2242-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-2242-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:11:53Z","timestamp":1611015113000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-2242-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2242"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-2242-9","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors confirm that the owner gave written consent for the publication of the horses\u2019 clinical details.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}